Jpmorgan Chase & CO Ideaya Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 67,751 shares of IDYA stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,751

Previous 92,970 27.13%

Holding current value

$2.03 Million

Previous $4.08 Million 41.7%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$34.37 - $43.46 $866,777 - $1.1 Million	-25,219 Reduced 27.13%	67,751 $2.38 Million
Q1 2024 May 10, 2024	SELL	$34.2 - $47.13 $804,657 - $1.11 Million	-23,528 Reduced 20.2%	92,970 $4.08 Million
Q4 2023 Feb 12, 2024	BUY	$24.59 - $35.83 $91,671 - $133,574	3,728 Added 3.31%	116,498 $4.14 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $46,543 - $65,761	2,209 Added 2.0%	112,770 $3.04 Million
Q2 2023 Aug 11, 2023	BUY	$13.33 - $25.53 $988,259 - $1.89 Million	74,138 Added 203.55%	110,561 $2.6 Million
Q1 2023 May 18, 2023	BUY	$13.49 - $18.72 $457,715 - $635,169	33,930 Added 1361.01%	36,423 $500,000
Q1 2023 May 11, 2023	SELL	$13.49 - $18.72 $343,941 - $477,285	-25,496 Reduced 91.09%	2,493 $34,000
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $81,393 - $102,206	5,625 Added 25.15%	27,989 $509,000
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $12,095 - $20,669	1,309 Added 6.22%	22,364 $334,000
Q2 2022 Aug 11, 2022	BUY	$8.28 - $13.88 $8,255 - $13,838	997 Added 4.97%	21,055 $291,000
Q1 2022 May 11, 2022	BUY	$11.18 - $24.02 $43,266 - $92,957	3,870 Added 23.91%	20,058 $224,000
Q4 2021 Feb 10, 2022	SELL	$20.95 - $26.88 $180,044 - $231,006	-8,594 Reduced 34.68%	16,188 $383,000
Q3 2021 Nov 12, 2021	BUY	$17.26 - $27.08 $427,737 - $671,096	24,782 New	24,782 $632,000

Others Institutions Holding IDYA

# of Institutions

213

Shares Held

73.8M

Call Options Held

21.5K

Put Options Held

20.3K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.44B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ideaya Biosciences, Inc. Transaction History